AnPac Bio-Medical Science Co., Ltd. — Form D

AnPac Bio-Medical Science Co., Ltd. of Lishui, F4, a company, filed a Form D exempt-offering notice with the SEC on 2022-05-27. The offering totals $1.4M, of which $1.4M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Chang YuDirectorLishui, F4
Chang YuExecutive OfficerLishui, F4
Lin YuDirectorIrvine, CA
Edward TangExecutive OfficerSan Mateo, CA
Aidong ChenDirectorLishui, F4
Aidong ChenExecutive OfficerLishui, F4
Jianhua ShaoDirectorLishui, F4
Jinqiu TangExecutive OfficerLishui, F4
Pu XingDirectorLishui, F4
Chris Chang YuDirectorLishui, F4
Chris Chang YuExecutive OfficerLishui, F4
He YuExecutive OfficerLishui, F4
Ren LuoDirectorLishui, F4
Feng GuoDirectorLishui, F4
Sheng LiuDirectorLishui, F4
XueDong DuExecutive OfficerLishui, F4
Weidong DaiExecutive OfficerLishui, F4
Sarah YuDirectorLishui, F4
Jiefeng GuExecutive OfficerLishui, F4
Yu ChrisDirectorLishui, F4
Yu ChrisExecutive OfficerLishui, F4

Other filings by this issuer (3)

FiledFormOfferingSold
2022-06-13D$1.5M$1.5M
2022-06-13D$1.5M$1.5M
2020-08-24D$265K$265K

More